Stryker マネジメント

マネジメント基準チェック /34

Strykerの CEO はKevin Loboで、 Oct2012年に任命され、の在任期間は 12.08年です。の年間総報酬は$ 20.77Mで、 6.7%給与と93.3%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の0.026%を直接所有しており、その価値は$ 39.29M 。経営陣と取締役会の平均在任期間はそれぞれ6.2年と6.5年です。

主要情報

Kevin Lobo

最高経営責任者

US$20.8m

報酬総額

CEO給与比率	6.7%
CEO在任期間	12.1yrs
CEOの所有権	0.03%
経営陣の平均在職期間	6.2yrs
取締役会の平均在任期間	6.5yrs

経営陣の近況

Recent updates

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Aug 21

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Aug 10

Stryker: Wait For A Better Entry Point Post-Q2 Results

Aug 06

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

Jul 11

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Jun 30

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

Jun 19

The Returns At Stryker (NYSE:SYK) Aren't Growing

Jun 16

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Jun 05

Stryker: Margin Gains Should Drive Upside

May 31

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

May 25

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

May 14

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 02

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Apr 29

Stryker: A Great Company At An Expensive Price

Apr 05

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Mar 26

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Mar 25

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

Mar 14

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Feb 21

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Feb 10

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Feb 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Jan 24

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Jan 02

Stryker: Mako Shoulder And Spine Launches Are On The Way

Dec 31

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 22

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 08

Why Stryker Is An Awesome Healthcare Compounder

Nov 30

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Nov 10

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Oct 19

Stryker: Don't Buy This Dividend Champion (Yet)

Oct 13

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Oct 08

Is Stryker (NYSE:SYK) A Risky Investment?

Sep 26

CEO報酬分析

Stryker の収益と比較して、Kevin Lobo の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Sep 30 2024	n/a	n/a	US$4b
Jun 30 2024	n/a	n/a	US$3b
Mar 31 2024	n/a	n/a	US$3b
Dec 31 2023	US$21m	US$1m	US$3b
Sep 30 2023	n/a	n/a	US$3b
Jun 30 2023	n/a	n/a	US$3b
Mar 31 2023	n/a	n/a	US$3b
Dec 31 2022	US$19m	US$1m	US$2b
Sep 30 2022	n/a	n/a	US$2b
Jun 30 2022	n/a	n/a	US$2b
Mar 31 2022	n/a	n/a	US$2b
Dec 31 2021	US$16m	US$1m	US$2b
Sep 30 2021	n/a	n/a	US$2b
Jun 30 2021	n/a	n/a	US$2b
Mar 31 2021	n/a	n/a	US$1b
Dec 31 2020	US$13m	US$1m	US$2b
Sep 30 2020	n/a	n/a	US$2b
Jun 30 2020	n/a	n/a	US$2b
Mar 31 2020	n/a	n/a	US$2b
Dec 31 2019	US$15m	US$1m	US$2b
Sep 30 2019	n/a	n/a	US$3b
Jun 30 2019	n/a	n/a	US$4b
Mar 31 2019	n/a	n/a	US$4b
Dec 31 2018	US$14m	US$1m	US$4b
Sep 30 2018	n/a	n/a	US$1b
Jun 30 2018	n/a	n/a	US$1b
Mar 31 2018	n/a	n/a	US$1b
Dec 31 2017	US$14m	US$1m	US$1b

報酬と市場: Kevinの総報酬 ($USD 20.77M ) は、 US市場 ($USD 12.73M ) の同規模の企業の平均を上回っています。

報酬と収益: Kevinの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Kevin Lobo (59 yo)

12.1yrs

在職期間

US$20,767,847

報酬

Mr. Kevin A. Lobo has been the Chief Executive Officer of Stryker Corporation since October 1, 2012 and serves as its President since October 01, 2021. He serves as Chairman of the Board at The Advanced Me...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Kevin Lobo	Chairman	12.1yrs	US$20.77m	0.026% $ 39.3m
Glenn Boehnlein	VP & CFO	8.6yrs	US$6.84m	0.0015% $ 2.3m
Viju Menon	Group President of Global Quality & Operations	6.6yrs	US$4.47m	0.0024% $ 3.6m
J. Pierce	Group President of MedSurg & Neurotechnology	6.3yrs	US$6.49m	0.015% $ 22.7m
Spencer Stiles	Group President of Orthopaedics & Spine	6.3yrs	US$6.49m	0.014% $ 20.4m
William Berry	VP & Chief Accounting Officer	3.3yrs	データなし	0.00078% $ 1.2m
Robert Cohen	CTO and VP of Global R&D - Joint Replacement	no data	データなし	データなし
Alan Douville	VP, Chief Information Officer & Chief Information Security Officer	6.2yrs	データなし	データなし
Jason Beach	Vice President of Finance & Investor Relations	2.3yrs	データなし	データなし
Robert Fletcher	VP & Chief Legal Officer	5.6yrs	US$2.24m	0.0024% $ 3.6m
Dana McMahon	VP & Chief Compliance Officer	no data	データなし	データなし
Yin Becker	VP of Communications	5.9yrs	データなし	0.0087% $ 12.9m

6.2yrs

平均在職期間

57yo

平均年齢

経験豊富な経営陣: SYKの経営陣は経験豊富で経験豊富です（平均在職期間は6.2年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Kevin Lobo	Chairman	12.1yrs	US$20.77m	0.026% $ 39.3m
Lisa Skeete Tatum	Independent Director	4.5yrs	US$319.25k	0.00085% $ 1.3m
Howard Cox	Director Emeritus	6.5yrs	US$38.86k	データなし
John Brown	Chairman Emeritus	no data	US$286.99k	5.26% $ 7.8b
Ronda Stryker	Independent Director	40.8yrs	US$319.25k	4.77% $ 7.1b
Mary Brainerd	Independent Director	7.3yrs	US$334.25k	0.0015% $ 2.3m
Allan Golston	Independent Director	13.8yrs	US$334.25k	0.0039% $ 5.8m
Sherilyn S. McCoy	Lead Independent Director	6.5yrs	US$359.25k	0.00022% $ 327.2k
Rajeev Suri	Independent Director	6.5yrs	US$319.25k	0.0014% $ 2.0m
Giovanni Caforio	Independent Director	3.9yrs	US$319.25k	0.00067% $ 996.5k
Andrew Silvernail	Independent Director	11yrs	US$339.25k	0.0015% $ 2.2m
Rachel Ruggeri	Independent Director	less than a year	データなし	0.000010% $ 14.9k

6.5yrs

平均在職期間

59yo

平均年齢

経験豊富なボード: SYKの取締役会は経験豊富であると考えられます ( 6.5年の平均在任期間)。

Stryker マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

Chairman exercised options and sold US$43m worth of stock

Independent Director recently sold US$84m worth of stock

Independent Director notifies of intention to sell stock

Independent Director notifies of intention to sell stock

VP & CFO recently sold US$6.7m worth of stock

VP & CFO exercised options and sold US$3.7m worth of stock

Recent updates

At US$386, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?

Stryker Unveils Oculan Lighting Platform to Enhance Surgical Visualization and Inumination

Chairman exercised options and sold US$43m worth of stock

Stryker Launches Next Generation of SurgiCount+ to Help Improve the Standard of Care in Hospitals for Sponge Management and Blood Loss Assessment

Independent Director recently sold US$84m worth of stock

Independent Director notifies of intention to sell stock

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker's Growth Via Continuous Acquisitions Led To Declining ROIC

Treace Medical Concepts, Inc. Files Lawsuit Against Stryker Corporation and Its Subsidiary Wright Medical Technology, Inc

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker Corporation (NYSE:SYK) completed the acquisition of Vertos Medical Inc.

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker Corporation (NYSE:SYK) acquired NICO Corporation.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) completed the acquisition of Care.ai inc.

Stryker Corporation (NYSE:SYK) acquired The Osteotomy Truss System (OTS) and Ankle Truss System of 4WEB Inc.

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Stryker Corporation (NYSE:SYK) entered into a definitive agreement to acquire Vertos Medical Inc.

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Stryker Corporation (NYSE:SYK) agreed to acquire Care.ai inc.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Second quarter dividend of US$0.80 announced

Independent Director notifies of intention to sell stock

Stryker Announces Launch of Pangea Plating System

Stryker: Wait For A Better Entry Point Post-Q2 Results

VP & CFO recently sold US$6.7m worth of stock

Stryker's Spine Guidance 5 Software Featuring Copilot Receives 510(K) Clearance from FDA

Second quarter 2024 earnings: EPS misses analyst expectations

Stryker Corporation (NYSE:SYK) completed the acquisition of Artelon, Inc.

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

VP & CFO exercised options and sold US$3.7m worth of stock

Stryker Corporation to Report Q2, 2024 Results on Jul 30, 2024

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

The Returns At Stryker (NYSE:SYK) Aren't Growing

Stryker Releases Lifepak 35 Monitor/Defibrillator

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) agreed to acquire Artelon, Inc.

Stryker: Margin Gains Should Drive Upside

First European Announces That Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

VP & CFO recently sold US$3.3m worth of stock

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

First quarter dividend of US$0.80 announced

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker: A Great Company At An Expensive Price

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

VP & Chief Accounting Officer notifies of intention to sell stock

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Fourth quarter dividend of US$0.80 announced

New minor risk - Insider selling

Independent Director recently sold US$100m worth of stock

Independent Director notifies of intention to sell stock

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Stryker Corporation Provides Earnings Guidance for the Year 2024

マネジメント基準チェック /34